Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with Paclitaxel-eluting stents

Keiichi Tsuchida; Andrew T.L. Ong; Jiro Aoki; Carlos A.G. Van Mieghem; Gastón A. Rodriguez-Granillo; Marco Valgimigli; Georgios Sianos; Evelyn Regar; Eugène P. McFadden; Willem J. Van Der Giessen; Pim J. De Feyter; Peter P.T. De Jaegere; Ron T. Van Domburg; Patrick W. Serruys

doi:10.1016/j.amjcard.2005.03.084

Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with Paclitaxel-eluting stents

Keiichi Tsuchida
, Andrew T.L. Ong
, Jiro Aoki
, Carlos A.G. Van Mieghem
, Gastón A. Rodriguez-Granillo
, Marco Valgimigli
, Georgios Sianos
, Evelyn Regar
, Eugène P. McFadden
, Willem J. Van Der Giessen
, Pim J. De Feyter
, Peter P.T. De Jaegere
, Ron T. Van Domburg
, Patrick W. Serruys

Erasmus MC

Research output: Contribution to a Journal (Peer & Non Peer) › Article › peer-review

35 Citations (Scopus)

Abstract

The aim of this study was to evaluate the outcome after paclitaxel-eluting stent implantation in 40 patients with 52 saphenous vein graft lesions. By Kaplan-Meier estimates, the probability of major adverse cardiac event-free survival for 1 year was 92.5%. A paclitaxel-eluting stent for saphenous vein graft disease appears to be feasible and safe, with a low rate of reintervention at 1 year, but late follow-up is needed to confirm these observations.

Original language	English
Pages (from-to)	395-398
Number of pages	4
Journal	American Journal of Cardiology
Volume	96
Issue number	3
DOIs	https://doi.org/10.1016/j.amjcard.2005.03.084
Publication status	Published - 1 Aug 2005
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.amjcard.2005.03.084

Cite this

Tsuchida, K., Ong, A. T. L., Aoki, J., Van Mieghem, C. A. G., Rodriguez-Granillo, G. A., Valgimigli, M., Sianos, G., Regar, E., McFadden, E. P., Van Der Giessen, W. J., De Feyter, P. J., De Jaegere, P. P. T., Van Domburg, R. T., & Serruys, P. W. (2005). Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with Paclitaxel-eluting stents. American Journal of Cardiology, 96(3), 395-398. https://doi.org/10.1016/j.amjcard.2005.03.084

@article{a3c2cbd0fe3d469dbf9a15377b9933a0,

title = "Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with Paclitaxel-eluting stents",

abstract = "The aim of this study was to evaluate the outcome after paclitaxel-eluting stent implantation in 40 patients with 52 saphenous vein graft lesions. By Kaplan-Meier estimates, the probability of major adverse cardiac event-free survival for 1 year was 92.5\%. A paclitaxel-eluting stent for saphenous vein graft disease appears to be feasible and safe, with a low rate of reintervention at 1 year, but late follow-up is needed to confirm these observations.",

author = "Keiichi Tsuchida and Ong, \{Andrew T.L.\} and Jiro Aoki and \{Van Mieghem\}, \{Carlos A.G.\} and Rodriguez-Granillo, \{Gast{\'o}n A.\} and Marco Valgimigli and Georgios Sianos and Evelyn Regar and McFadden, \{Eug{\`e}ne P.\} and \{Van Der Giessen\}, \{Willem J.\} and \{De Feyter\}, \{Pim J.\} and \{De Jaegere\}, \{Peter P.T.\} and \{Van Domburg\}, \{Ron T.\} and Serruys, \{Patrick W.\}",

year = "2005",

month = aug,

day = "1",

doi = "10.1016/j.amjcard.2005.03.084",

language = "English",

volume = "96",

pages = "395--398",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "3",

}

Tsuchida, K, Ong, ATL, Aoki, J, Van Mieghem, CAG, Rodriguez-Granillo, GA, Valgimigli, M, Sianos, G, Regar, E, McFadden, EP, Van Der Giessen, WJ, De Feyter, PJ, De Jaegere, PPT, Van Domburg, RT & Serruys, PW 2005, 'Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with Paclitaxel-eluting stents', American Journal of Cardiology, vol. 96, no. 3, pp. 395-398. https://doi.org/10.1016/j.amjcard.2005.03.084

TY - JOUR

T1 - Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with Paclitaxel-eluting stents

AU - Tsuchida, Keiichi

AU - Ong, Andrew T.L.

AU - Aoki, Jiro

AU - Van Mieghem, Carlos A.G.

AU - Rodriguez-Granillo, Gastón A.

AU - Valgimigli, Marco

AU - Sianos, Georgios

AU - Regar, Evelyn

AU - McFadden, Eugène P.

AU - Van Der Giessen, Willem J.

AU - De Feyter, Pim J.

AU - De Jaegere, Peter P.T.

AU - Van Domburg, Ron T.

AU - Serruys, Patrick W.

PY - 2005/8/1

Y1 - 2005/8/1

N2 - The aim of this study was to evaluate the outcome after paclitaxel-eluting stent implantation in 40 patients with 52 saphenous vein graft lesions. By Kaplan-Meier estimates, the probability of major adverse cardiac event-free survival for 1 year was 92.5%. A paclitaxel-eluting stent for saphenous vein graft disease appears to be feasible and safe, with a low rate of reintervention at 1 year, but late follow-up is needed to confirm these observations.

AB - The aim of this study was to evaluate the outcome after paclitaxel-eluting stent implantation in 40 patients with 52 saphenous vein graft lesions. By Kaplan-Meier estimates, the probability of major adverse cardiac event-free survival for 1 year was 92.5%. A paclitaxel-eluting stent for saphenous vein graft disease appears to be feasible and safe, with a low rate of reintervention at 1 year, but late follow-up is needed to confirm these observations.

UR - https://www.scopus.com/pages/publications/23044442806

U2 - 10.1016/j.amjcard.2005.03.084

DO - 10.1016/j.amjcard.2005.03.084

M3 - Article

C2 - 16054466

AN - SCOPUS:23044442806

SN - 0002-9149

VL - 96

SP - 395

EP - 398

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 3

ER -

Immediate and one-year outcome of percutaneous intervention of saphenous vein graft disease with Paclitaxel-eluting stents

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this